All eyes on Amsterdam

Article

"Recognising the trend amongst European ophthalmologists to sub-specialise has been a high priority for the European Society of Ophthalmology," its president Gabriel van Rij told Ophthalmology Times Europe.

"Recognising the trend amongst European ophthalmologists to sub-specialise has been a high priority for the European Society of Ophthalmology," its president Gabriel van Rij told Ophthalmology Times Europe. With over different 72 sessions during its 17th congress in June this year the Societas Ophthalmologica Europaea (SOE) potentially has something to offer every European doctor.

The SOE, which was established in 1956, invites all the major sub-speciality societies to take part in the preparation of its Congress, which, in turn, provides delegates with an event where they can meet and learn from leaders in each branch of ophthalmology.

"Our overall mission," explains Dr van Rij, "is of course to promote ophthalmology in Europe and to stimulate co-operation between European ophthalmologists and their National Societies. However, the world has changed since 1956 and so have we - fostering collaboration with all sub-speciality societies and supranational organisations with Europe and even beyond is now key."

The scientific programme of course includes cataract & refractive, retina, glaucoma and cornea but delegates interested in oncology & pathology, oculoplastics, paediatrics and strabismus, education, women in ophthalmology, neuro-ophthalmology, uveitis, electrophysiology or ocular trauma will not miss out. To see the symposia programme in full detail click here.

The congress is English speaking and takes place every two years. This year's event is in Amsterdam. "We are conscious of the variation in resources available across Europe, especially in today's economic climate," continued van Rij. "Subsequently, we provide reduced congress registration fees for most Eastern European delegates and each year we offer 70 educational travel grants for east-European ophthalmologists-in-training. These help young doctors not just financially but open doors to sub-specialist departments in all the major European centres."

"Another SOE innovation last year was the Young Ophthalmologist Programme open to residents and young specialists up to five years after board certification. The programme consists of an open forum for exchange of ideas and information about training, advice on observerships, fellowships and career building. Led sessions will be organised at major conferences and social events."

Getting a level playing field in education across Europe is a key challenge according to Dr van Rij: "There are countries where you can be an ophthalmologist in one year and countries where you need at least five years training. That presents many issues and challenges."

For more details go to www.soe2009.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.